Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Beverly Winikoff

Showing results (151-160 of 204) with videos related to

Pageof 21
Sort By:
Lancet (London, England)|August 6, 2019
Oral antihypertensive regimens (nifedipine retard, labetalol, and methyldopa) for management of severe hypertension in pregnancy: an open-label, randomised controlled trialThomas Easterling, Shuchita Mundle, Hillary Bracken, et al.
Contraception|February 3, 2023
Mailing abortion pills does not delay care: A cohort study comparing mailed to in-person dispensing of abortion medications in the United StatesLeah R Koenig, Elizabeth G Raymond, Marji Gold, et al.
The European Journal of Contraception & Reproductive Health Care : the Official Journal of the European Society of Contraception|October 30, 2024
Feasibility and acceptability of outpatient medical induction at 13-18 weeks' gestation in public sector hospitals in Nepal: a prospective cohort studyAnand Tamang, Ilana G Dzuba, Heera Tuladhar, et al.
Tropical Medicine & International Health : TM & IH|March 11, 2020
High fever after sublingual administration of misoprostol for treatment of post-partum haemorrhage: a hospital-based, prospective observational study in ArgentinaJill Durocher, Jesus Daniel Aguirre, Ilana G Dzuba, et al.
Plos One|October 2, 2019
Does route matter? Impact of route of oxytocin administration on postpartum bleeding: A double-blind, randomized controlled trialJill Durocher, Ilana G Dzuba, Guillermo Carroli, et al.
Contraception|February 5, 2020
Sensitivity and specificity of placental proteins for gestational age screening: An exploratory studyElizabeth G Raymond, Laura J Frye, Mark A Weaver, et al.
Obstetrics and Gynecology|October 15, 2016
Simultaneous Administration Compared With a 24-Hour Mifepristone-Misoprostol Interval in Second-Trimester Abortion: A Randomized Controlled TrialDina Fatima Abbas, Jennifer Blum, Nguyen Thi Nhu Ngoc, et al.
Reproductive Health Matters|February 23, 2015
Safety, efficacy and acceptability of outpatient mifepristone-misoprostol medical abortion through 70 days since last menstrual period in public sector facilities in Mexico CityPatricio Sanhueza Smith, Melanie Peña, Ilana G Dzuba, et al.
BMC Pregnancy and Childbirth|July 30, 2021
Oral Misoprostol alone versus oral misoprostol followed by oxytocin for labour induction in women with hypertension in pregnancy (MOLI): protocol for a randomised controlled trialHillary Bracken, Kate Lightly, Shuchita Mundle, et al.
BMC Women'S Health|August 1, 2016
Self-administered multi-level pregnancy tests in simplified follow-up of medical abortion in TunisiaRasha Dabash, Tara Shochet, Selma Hajri, et al.
Pageof 21

Showing results (151-160 of 204) with videos related to

Sort By:
Pageof 21
Lancet (London, England)|August 6, 2019
Oral antihypertensive regimens (nifedipine retard, labetalol, and methyldopa) for management of severe hypertension in pregnancy: an open-label, randomised controlled trialThomas Easterling, Shuchita Mundle, Hillary Bracken, et al.
Contraception|February 3, 2023
Mailing abortion pills does not delay care: A cohort study comparing mailed to in-person dispensing of abortion medications in the United StatesLeah R Koenig, Elizabeth G Raymond, Marji Gold, et al.
The European Journal of Contraception & Reproductive Health Care : the Official Journal of the European Society of Contraception|October 30, 2024
Feasibility and acceptability of outpatient medical induction at 13-18 weeks' gestation in public sector hospitals in Nepal: a prospective cohort studyAnand Tamang, Ilana G Dzuba, Heera Tuladhar, et al.
Tropical Medicine & International Health : TM & IH|March 11, 2020
High fever after sublingual administration of misoprostol for treatment of post-partum haemorrhage: a hospital-based, prospective observational study in ArgentinaJill Durocher, Jesus Daniel Aguirre, Ilana G Dzuba, et al.
Plos One|October 2, 2019
Does route matter? Impact of route of oxytocin administration on postpartum bleeding: A double-blind, randomized controlled trialJill Durocher, Ilana G Dzuba, Guillermo Carroli, et al.
Contraception|February 5, 2020
Sensitivity and specificity of placental proteins for gestational age screening: An exploratory studyElizabeth G Raymond, Laura J Frye, Mark A Weaver, et al.
Obstetrics and Gynecology|October 15, 2016
Simultaneous Administration Compared With a 24-Hour Mifepristone-Misoprostol Interval in Second-Trimester Abortion: A Randomized Controlled TrialDina Fatima Abbas, Jennifer Blum, Nguyen Thi Nhu Ngoc, et al.
Reproductive Health Matters|February 23, 2015
Safety, efficacy and acceptability of outpatient mifepristone-misoprostol medical abortion through 70 days since last menstrual period in public sector facilities in Mexico CityPatricio Sanhueza Smith, Melanie Peña, Ilana G Dzuba, et al.
BMC Pregnancy and Childbirth|July 30, 2021
Oral Misoprostol alone versus oral misoprostol followed by oxytocin for labour induction in women with hypertension in pregnancy (MOLI): protocol for a randomised controlled trialHillary Bracken, Kate Lightly, Shuchita Mundle, et al.
BMC Women'S Health|August 1, 2016
Self-administered multi-level pregnancy tests in simplified follow-up of medical abortion in TunisiaRasha Dabash, Tara Shochet, Selma Hajri, et al.
Pageof 21